Hostname: page-component-cd9895bd7-q99xh Total loading time: 0 Render date: 2024-12-27T12:59:49.444Z Has data issue: false hasContentIssue false

Developmental decrease in REM sleep: the shift to kainate receptor regulation

Published online by Cambridge University Press:  18 April 2006

T. Kobayashi
Affiliation:
Department of Neurobiology & Developmental Sciences, Center for Translational Neuroscience, University of Arkansas for Medical Sciences, 4301 West Markham St., Slot 510, Little Rock, AR 72205, USA
R.D. Skinner
Affiliation:
Department of Neurobiology & Developmental Sciences, Center for Translational Neuroscience, University of Arkansas for Medical Sciences, 4301 West Markham St., Slot 510, Little Rock, AR 72205, USA
E. Garcia-Rill
Affiliation:
Department of Neurobiology & Developmental Sciences, Center for Translational Neuroscience, University of Arkansas for Medical Sciences, 4301 West Markham St., Slot 510, Little Rock, AR 72205, USA

Abstract

We found a shift in the responsiveness of pedunculopontine neurons from N-methyl-D-aspartic acid (NMDA) to kainic acid (KA) regulation around 15 days of age. While rapid eye movement (REM) sleep in humans decreases from 50 to 15% of sleep time between birth and the end of puberty, a similar decrease in the rat occurs from 10 to 30 days postnatally. Intracellularly recorded type II cholinergic PPN neurons, known to modulate waking and REM sleep, showed a gradual decrease in responsiveness to NMDA, and an increase in responsiveness to KA, during this period. Non-cholinergic PPN neurons did not show a developmental-dependent change in responsiveness. These results do not help explain if KA and NMDA control the developmental decrease in REM sleep, however, the data indicate that the shift at ∼15 days suggests that REM sleep becomes selectively modulated by KA receptors in the adult. Therefore, given development of appropriate compounds, KA receptor antagonism may become an effective treatment for disorders that manifest increased REM sleep drive and produce frequent nocturnal arousals and awakenings, e.g. schizophrenia, anxiety, insomnia, etc.

Type
Research Article
Copyright
Elsevier Science Ltd

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)